135 related articles for article (PubMed ID: 38820700)
21. Cost-effectiveness of Initiating an Insulin Pump in T1D Adults Using Continuous Glucose Monitoring Compared with Multiple Daily Insulin Injections: The DIAMOND Randomized Trial.
Wan W; Skandari MR; Minc A; Nathan AG; Zarei P; Winn AN; O'Grady M; Huang ES
Med Decis Making; 2018 Nov; 38(8):942-953. PubMed ID: 30403576
[TBL] [Abstract][Full Text] [Related]
22. Cost-effectiveness analysis of real-time continuous monitoring glucose compared to self-monitoring of blood glucose for diabetes mellitus in Spain.
García-Lorenzo B; Rivero-Santana A; Vallejo-Torres L; Castilla-Rodríguez I; García-Pérez S; García-Pérez L; Perestelo-Pérez L
J Eval Clin Pract; 2018 Aug; 24(4):772-781. PubMed ID: 29971893
[TBL] [Abstract][Full Text] [Related]
23. Cost-effectiveness of continuous glucose monitoring with FreeStyle Libre
Bahia L; Mello KF; Lemos LLP; Costa NL; Mulinari E; Malerbi DA
Diabetol Metab Syndr; 2023 Nov; 15(1):242. PubMed ID: 38001509
[TBL] [Abstract][Full Text] [Related]
24. Long-term health economic benefits of sensor-augmented pump therapy vs continuous subcutaneous insulin infusion alone in type 1 diabetes: a U.K. perspective.
Roze S; Smith-Palmer J; Valentine WJ; Cook M; Jethwa M; de Portu S; Pickup JC
J Med Econ; 2016; 19(3):236-42. PubMed ID: 26510389
[TBL] [Abstract][Full Text] [Related]
25. Self-monitoring of blood glucose (SMBG) for type 2 diabetes patients treated with oral anti-diabetes drugs and with a recent history of monitoring: cost-effectiveness in the US.
Tunis SL; Minshall ME
Curr Med Res Opin; 2010 Jan; 26(1):151-62. PubMed ID: 19919376
[TBL] [Abstract][Full Text] [Related]
26. Cost-effectiveness of continuous glucose monitoring and intensive insulin therapy for type 1 diabetes.
McQueen RB; Ellis SL; Campbell JD; Nair KV; Sullivan PW
Cost Eff Resour Alloc; 2011 Sep; 9():13. PubMed ID: 21917132
[TBL] [Abstract][Full Text] [Related]
27. Cost effectiveness of self-monitoring of blood glucose (SMBG) for patients with type 2 diabetes and not on insulin: impact of modelling assumptions on recent Canadian findings.
Tunis SL
Appl Health Econ Health Policy; 2011 Nov; 9(6):351-65. PubMed ID: 21892840
[TBL] [Abstract][Full Text] [Related]
28. Cost-Effectiveness of Hybrid Closed Loop Insulin Pumps Versus Multiple Daily Injections Plus Intermittently Scanned Glucose Monitoring in People With Type 1 Diabetes in The Netherlands.
Serné EH; Roze S; Buompensiere MI; Valentine WJ; De Portu S; de Valk HW
Adv Ther; 2022 Apr; 39(4):1844-1856. PubMed ID: 35226346
[TBL] [Abstract][Full Text] [Related]
29. A European Cost-Utility Analysis of the MiniMed™ 780G Advanced Hybrid Closed-Loop System Versus Intermittently Scanned Continuous Glucose Monitoring with Multiple Daily Insulin Injections in People Living with Type 1 Diabetes.
Jendle J; Buompensiere MI; Ozdemir Saltik AZ; de Portu S; Smith-Palmer J; Pollock RF; Cohen O
Diabetes Technol Ther; 2023 Dec; 25(12):864-876. PubMed ID: 37801658
[No Abstract] [Full Text] [Related]
30. Cost-utility analysis of a flash continuous glucose monitoring system in the management of people with type 2 diabetes mellitus on basal insulin therapy-An Italian healthcare system perspective.
Del Prato S; Giorgino F; Szafranski K; Poon Y
Diabetes Obes Metab; 2024 Jun; ():. PubMed ID: 38853717
[TBL] [Abstract][Full Text] [Related]
31. Continuous glucose monitoring for patients with diabetes: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2011; 11(4):1-29. PubMed ID: 23074416
[TBL] [Abstract][Full Text] [Related]
32. Cost-effectiveness of a novel hybrid closed-loop system compared with continuous subcutaneous insulin infusion in people with type 1 diabetes in the UK.
Roze S; Buompensiere MI; Ozdemir Z; de Portu S; Cohen O
J Med Econ; 2021; 24(1):883-890. PubMed ID: 34098834
[TBL] [Abstract][Full Text] [Related]
33. Continuous glucose monitoring systems for type 1 diabetes mellitus.
Langendam M; Luijf YM; Hooft L; Devries JH; Mudde AH; Scholten RJ
Cochrane Database Syst Rev; 2012 Jan; 1(1):CD008101. PubMed ID: 22258980
[TBL] [Abstract][Full Text] [Related]
34. Cost-effectiveness of sensor-augmented pump therapy in two different patient populations with type 1 diabetes in Italy.
Nicolucci A; Rossi MC; D'Ostilio D; Delbaere A; de Portu S; Roze S
Nutr Metab Cardiovasc Dis; 2018 Jul; 28(7):707-715. PubMed ID: 29753586
[TBL] [Abstract][Full Text] [Related]
35. Estimating the cost-effectiveness of intermittently scanned continuous glucose monitoring in adults with type 1 diabetes in England.
Elliott RA; Rogers G; Evans ML; Neupane S; Rayman G; Lumley S; Cranston I; Narendran P; Sutton CJ; Taxiarchi VP; Burns M; Thabit H; Wilmot EG; Leelarathna L;
Diabet Med; 2024 Mar; 41(3):e15232. PubMed ID: 37750427
[TBL] [Abstract][Full Text] [Related]
36. Self-monitoring of blood glucose in type 2 diabetes: cost-effectiveness in the united states.
Tunis SL; Minshall ME
Am J Manag Care; 2008 Mar; 14(3):131-40. PubMed ID: 18333705
[TBL] [Abstract][Full Text] [Related]
37. Cost-Effectiveness of the FreeStyle Libre
Jendle J; Eeg-Olofsson K; Svensson AM; Franzen S; Lamotte M; Levrat-Guillen F
Diabetes Ther; 2021 Dec; 12(12):3137-3152. PubMed ID: 34694584
[TBL] [Abstract][Full Text] [Related]
38. Is Reconstruction of Unstable Midfoot Charcot Neuroarthropathy Cost Effective from a US Payer's Perspective?
Albright RH; Joseph RM; Wukich DK; Armstrong DG; Fleischer AE
Clin Orthop Relat Res; 2020 Dec; 478(12):2869-2888. PubMed ID: 32694315
[TBL] [Abstract][Full Text] [Related]
39. CONTINUOUS GLUCOSE MONITORING: A CONSENSUS CONFERENCE OF THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY.
Fonseca VA; Grunberger G; Anhalt H; Bailey TS; Blevins T; Garg SK; Handelsman Y; Hirsch IB; Orzeck EA; Roberts VL; Tamborlane W;
Endocr Pract; 2016 Aug; 22(8):1008-21. PubMed ID: 27214060
[TBL] [Abstract][Full Text] [Related]
40. Cost-Effectiveness of a Continuous Glucose Monitoring Mobile App for Patients With Type 2 Diabetes Mellitus: Analysis Simulation.
Tsuji S; Ishikawa T; Morii Y; Zhang H; Suzuki T; Tanikawa T; Nakaya J; Ogasawara K
J Med Internet Res; 2020 Sep; 22(9):e16053. PubMed ID: 32940613
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
